- Q1. What is the business of Sahajanand Medical Technologies Limited ?It develops and manufactures advanced cardiovascular medical devices like coronary stents, balloons, valves and occluders used for vascular intervention and structural heart treatments globally.
- Q2. Why is the company raising funds via IPO?The IPO is mainly an Offer For Sale (OFS) to enable existing investors to unlock value and list the company publicly.
- Q3. What is the size of the issue and where will it list?The issue size of the IPO comprises entirely an OFS of ~2.76 Cr equity shares. It will be listed on BSE and NSE platform.
- Q4. What are the key risks to an investor?Key risks include dependence on cardiovascular products, strict regulatory approvals in medical devices, pricing controls on stents, and strong competition from global medical technology companies.
- Q5. What are the potential upsides?The company benefits from strong R&D, global presence in 70+ countries, growing demand for minimally invasive cardiac treatments, and increasing adoption of advanced medical devices.
- Q6. How to apply for the IPO?Investors can apply for the IPO through ASBA via net banking or using UPI through registered stock brokers once the IPO opens for subscription.
- Toggle TitleToggle Content
Closed
Sahajanand Medical Technologies Limited: New IPO, GMP, Price, Profit, Analysis, IPO Score
0
IPO Score
0
*Score varies on actual price
Sahajanand Medical Technologies Limited is an R&D-driven medical device manufacturer specializing in advanced cardiovascular devices such as coronary stents, balloons, and structural heart solutions. The company focuses on vascular intervention and structural heart treatments, with its products used in hospitals across more than 70 countries.
It has filed its draft red herring prospectus with the Securities and Exchange Board of India (SEBI) to initiate an Initial Public Offering (IPO) with an issue size of ₹ 475.48 Crores which consists entirely as an Offer-for-Sale (OFS) of ₹ 475.48 Crores by existing investors.
Sahajanand Medical Technologies Limited was incorporated on 2001 & currently Mr. Bhargav Dhirajlal Kotadia serves as the Managing Director & Chief Executive Officer (CEO) of the company.
It develops and manufactures cardiovascular medical devices, mainly coronary stents, balloon catheters, trans-catheter aortic valves (TAVI) and occluders used in vascular and structural heart treatments. It’s supplies its products to 75+ countries worldwide, supplying hospitals and cardiology centres globally. The company holds ~25% market share in India’s Drug-Eluting Stent (DES) segment by sales volume.
Subscription date to apply for Sahajanand Medical Technologies Limited starts on 15th Oct’26 & closes on 19th Oct’26. Price band for the IPO is ₹327 to ₹344 with a lot size of 43 Shares.
Revenue, PAT, EBITDA
Year |
2025 |
|---|---|
Networth
|
₹ 545.23 Cr
|
Revenue
|
₹ 1024.87 Cr
|
EBITDA
|
₹ 128.02 Cr
|
PAT
|
₹ 25.15 Cr
|
EBITDA Margin
|
~12.49%
|
PAT Margin
|
~2.45%
|
Face Value
|
Rs.1 per Equity Share
|
IPO Important Dates
# |
Date |
|---|---|
Open Date
|
15-Oct'26
|
Close Date
|
19-Oct'26
|
Anchor Investor Bidding
|
14-Oct'26
|
Allotment Date
|
21-Oct'26
|
Refunds& Demat Credit
|
22-Oct'26
|
Tentative Listing Date
|
23-Oct'26
|
Use Of Proceeds
Purpose |
Amount |
|---|---|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Entirely as Offer for Sale
|
-
|
Financial Data
# |
2023 |
2024 |
2025 |
|---|---|---|---|
Revenue (₹ Cr)
|
₹ 795.5
|
₹ 901.6
|
₹ 1,024.9
|
PAT (₹ Cr)
|
₹ 11.9
|
₹ -7.4
|
₹ 25.2
|
Asset (₹ Cr)
|
₹ 911.6
|
₹ 970.6
|
₹ 1,094.9
|
Net Worth (₹ Cr)
|
₹ 539.2
|
₹ 526.3
|
₹ 545.2
|
IPO Grey Market Premium
Date |
IPO Price |
IPO GMP |
Profit Per Lot |
|---|---|---|---|
19-Oct
|
₹ 327 - ₹ 344
|
₹ 26
|
₹ 1,118
|
18-Oct
|
₹ 327 - ₹ 344
|
₹ 20
|
₹ 860
|
17-Oct
|
₹ 327 - ₹ 344
|
₹ 40
|
₹ 1,720
|
16-Oct
|
₹ 327 - ₹ 344
|
₹ 41
|
₹ 1763
|
15-Oct
|
₹ 327 - ₹ 344
|
₹ 40
|
₹ 1,720
|
Promoters – Pre offer equity (Approx)
Promoters |
% Shares |
|---|---|
Shree Hari Trust
|
~ 36.79 %
|
Dhirajkumar Savjibhai Vasoya
|
~ 4.03 %
|
Sahajanand Technologies Private Limited
|
~ 0.06 %
|
Jitendra Vallabhbhai Kotadia
|
~ 0.03 %
|
-
|
-
|
-
|
-
|
Lot Size details
Application Type |
Lot Size |
No. of Lot |
No. of Shares |
Investment Amount |
|---|---|---|---|---|
Retail (Min)
|
43 Shares
|
1
|
43 Shares
|
₹ 14,061
|
Retail (Max)
|
43 Shares
|
13
|
559 Shares
|
₹ 1,92,296
|
HNI (Min)
|
43 Shares
|
14
|
602 Shares
|
₹ 1,96,854
|
HNI (Max)
|
43 Shares
|
66
|
2,838 Shares
|
₹ 9,76,272
|
Big HNI (Min)
|
43 Shares
|
67
|
2,881 Shares
|
₹ 9,42,087
|
Key Performance Index (KPI)
ROE |
10.35% |
|---|---|
ROCE
|
11.57%
|
RoNW
|
10.60%
|
JOIN OUR SOCIAL-MEDIA PLATFORMS TO STAY UPDATED
Checkout more upcoming IPO's
Jio Platforms Limited IPO: GMP today, Price, Review, Detail, IPO Price
Jio Platforms Limited is a digital technology company and the holding company for Reliance’s digital...
Read More
National Stock Exchange of India (NSE): IPO Analysis, GMP Details, IPO Score
National Stock Exchange of India Limited (NSE) operates India’s leading stock exchange and provides trading,...
Read More
Pioneer Fil-Med Limited
Pioneer Fil-Med Limited is engaged in manufacturing railway, metro and renewable energy components, including traction...
Read More
SBI Funds Management Limited
SBI Funds Management Limited is a leading asset management company engaged in managing mutual funds...
Read More
OnEMI Technology Solutions Limited
OnEMI Technology Solutions Limited is a technology-enabled digital lending company that operates the Kissht platform,...
Read More